The optimal use of PET/CT in the management of lymphoma patients.
Sarah Allison MilgromLaura RechnerAnne BerthelsenPublished in: The British journal of radiology (2021)
18F-fluoro-deoxyglucose positron emission tomography (PET)/computed tomography (CT) scans play an important role in the management of lymphoma patients. They are critical to accurately stage disease and assess its response to therapy. In addition, PET/CT scans enable precise target delineation for radiation therapy planning. In this review, we describe the use of PET/CT scans in lymphoma, with a focus on their role in staging disease, assessing response to therapy, predicting prognosis, and planning RT.
Keyphrases
- positron emission tomography
- pet ct
- computed tomography
- end stage renal disease
- radiation therapy
- ejection fraction
- dual energy
- chronic kidney disease
- newly diagnosed
- magnetic resonance imaging
- diffuse large b cell lymphoma
- pet imaging
- peritoneal dialysis
- image quality
- prognostic factors
- squamous cell carcinoma
- lymph node
- stem cells
- bone marrow
- smoking cessation
- locally advanced
- radiation induced